|4Feb 23, 4:44 PM ET

SCHWAB JOHN R 4

4 · Vertex, Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Vertex (VERX) CFO John R. Schwab Receives RSU Award

What Happened

  • John R. Schwab, Chief Financial Officer of Vertex, Inc., received a grant of 269,399 restricted stock units (RSUs) reported on Form 4 for a Feb 19, 2026 transaction. The filing lists the acquisition price as $0.00 (derivative award), i.e., no cash was paid at grant. Each RSU represents a contingent right to one share of Class A common stock (see footnote F1).

Key Details

  • Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (filed within the required two business days).
  • Transaction type/code: A — grant/award of derivative securities (RSUs).
  • Quantity: 269,399 RSUs; reported price: $0.00 (derivative award).
  • Vesting: 25% vests on each of Feb 19, 2027; Feb 19, 2028; Feb 19, 2029; and Feb 19, 2030 (footnote F2).
  • Shares owned after transaction: not reported in the supplied details of this summary.
  • Footnotes: F1 clarifies each RSU converts to one share when/if settled; F2 gives the four-year annual vesting schedule.

Context

  • RSU grants are a form of compensation and do not represent an open-market purchase or sale; they vest over time and typically align executive incentives with shareholders but do not by themselves signal immediate buying or selling. This filing appears timely and routine for an executive compensation award.

Insider Transaction Report

Form 4
Period: 2026-02-19
SCHWAB JOHN R
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-02-19+269,399269,399 total
    Class A Common Stock (269,399 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuers Class A Common Stock.
  • [F2]Represents an award of restricted stock units that will vest as to 25% of the amount of shares on each of February 19, 2027, February 19, 2028, February 19, 2029 and February 19, 2030.
Signature
/s/ Lisa Coleman, Attorney-in-Fact|2026-02-23

Documents

1 file
  • 4
    form4-02232026_090250.xmlPrimary